A substantial advancement in blood sugar care is emerging with the approval of tirzepatide at a dosage of 45mg. This updated version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, and https://zoyakdhs727544.wikirecognition.com/2289053/revolutionary_approach_tirzepatide_dose_for_diabetes_regulation